Back to Search
ALLA ELDIN BABIKER, M.D
M.D
Internal Medicine Physician
NPI: 1871536722Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
28043(AZ)
Research & Publications (20)
Spatial and temporal distribution of the malaria mosquito Anopheles arabiensis in northern Sudan: influence of environmental factors and implications for vector control.
PMID 19500425·Malar J·2009
7-preclinical
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial.
PMID 19059639·Lancet·2009
4-observational
Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1.
PMID 18845810·Circ Res·2008
7-preclinical
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.
PMID 18502002·Vaccine·2008
3-trial
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial.
PMID 18765698·Ann Intern Med·2008
4-observational
Early antiretroviral therapy and mortality among HIV-infected infants.
PMID 19020325·N Engl J Med·2008
3-trial
Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART).
PMID 18923700·Open AIDS J·2008
8-other
A one-step DNA PCR-based method for the detection of Mycobacterium tuberculosis complex grown on Lowenstein-Jensen media.
PMID 18256436·Am J Trop Med Hyg·2008
8-other
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.
PMID 18502003·Vaccine·2008
3-trial
The long-term effects of a peer-led sex education programme (RIPPLE): a cluster randomised trial in schools in England.
PMID 19067478·PLoS Med·2008
2-rct
Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
PMID 18476293·J Infect Dis·2008
4-observational
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.
PMID 18476292·J Infect Dis·2008
4-observational
Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers.
PMID 18812202·Vaccine·2008
3-trial
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
PMID 18826546·HIV Med·2008
6-review
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.
PMID 18195071·J Exp Med·2008
2-rct
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
PMID 18356603·AIDS·2008
2-rct
A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.
PMID 17631681·Malar J·2007
4-observational
A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan.
PMID 18074034·PLoS One·2007
2-rct
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count.
PMID 17690569·AIDS·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 11518 N FRONTAGE RD
YUMA, AZ 85367 - Phone
- (928) 342-6500
Quick Facts
- NPI
- 1871536722
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile